Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Papadakis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|September 27, 2003
Infliximab in the treatment of medically refractory indeterminate colitisK A Papadakis, L Treyzon, M T Abreu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune systemK A Papadakis, J Prehn, V Nelson, et al.
The American Journal of Gastroenterology|July 27, 2001
Outcome of cytomegalovirus infections in patients with inflammatory bowel diseaseK A Papadakis, J K Tung, S W Binder, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2012
Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomesA Arranz, C Reinsch, K A Papadakis, et al.
Gastroenterology|December 2, 1999
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's diseaseE A Vasiliauskas, L Y Kam, M T Abreu-Martin, et al.
Endoscopy|December 7, 2007
Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU)S Mehdizadeh, G Chen, P J Enayati, et al.
Oncogene|August 18, 2015
Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesisK K Gkouskou, M Ioannou, G A Pavlopoulos, et al.
Gastroenterology|August 7, 2001
CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's diseaseK A Papadakis, J Prehn, S T Moreno, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|September 27, 2003
Infliximab in the treatment of medically refractory indeterminate colitisK A Papadakis, L Treyzon, M T Abreu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune systemK A Papadakis, J Prehn, V Nelson, et al.
The American Journal of Gastroenterology|July 27, 2001
Outcome of cytomegalovirus infections in patients with inflammatory bowel diseaseK A Papadakis, J K Tung, S W Binder, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2012
Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomesA Arranz, C Reinsch, K A Papadakis, et al.
Gastroenterology|December 2, 1999
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's diseaseE A Vasiliauskas, L Y Kam, M T Abreu-Martin, et al.
Endoscopy|December 7, 2007
Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU)S Mehdizadeh, G Chen, P J Enayati, et al.
Oncogene|August 18, 2015
Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesisK K Gkouskou, M Ioannou, G A Pavlopoulos, et al.
Gastroenterology|August 7, 2001
CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's diseaseK A Papadakis, J Prehn, S T Moreno, et al.
Pageof 2